Nuclear magnetic resonance spectroscopy: A review of neuropsychiatric applications

Achten, 1993, Multiparameter MRI and MRS of the Temporal Lobe in Normal Subjects and in Patients with Complex Partial Seizures, SMRM Book of Abstracts, 1, 482 Ackerman, 1980, Mapping of Metabolites in Whole Animals by 31-PNMR Using Surface Coils, Nature, 283, 167, 10.1038/283167a0 Albert, 1990, In vivo 19F Nuclear Magnetic Resonance Spectroscopy of Trifluorinated Neuroleptics in the Rat, NMR Biomed., 3, 120, 10.1002/nbm.1940030304 Arndt, 1988, 19F Magnetic Resonance Imaging and Spectroscopy of a Fluorinated Neuroleptic Ligand: in vivo and in vitro Studies, Psychiatry Res., 25, 73, 10.1016/0165-1781(88)90160-6 Arnold, 1990, Proton Magnetic Resonance Spectroscopy of Human Brain in Vivo in the Evaluation of Multiple Sclerosis: Assessment of the Load of Disease, Magn. Reson. Med., 14, 154, 10.1002/mrm.1910140115 Aue, 1986, Localization Methods for in vivo Nuclear Magnetic Resonance Spectroscopy, Rev. Magn. Reson. Med., 1, 21 Barany, 1985, Increased Glycerol-3-phosphocholine in postmortem Alzheimer's brain letter, Lancet., 1, 517, 10.1016/S0140-6736(85)92114-2 Barranco, 1989, Use of 19F NMR Spectroscopy for Measurement of Cerebral Blood Flow: A Comparative Study Using Microspheres, J. Cereb. Blood Flow Metab., 9, 886, 10.1038/jcbfm.1989.122 Bartels, 1986, Fluorinated Psyschopharmacological Agents: Noninvasive Observation by Fluorine-19 Nuclear Magnetic Resonance, Psychiatry. Rev., 18, 197 Bartels, 1991, 19F Nuclear Magnetic Resonance Spectroscopy of Neuroleptics: The First in vivo Pharmacokinetics of Trifluoperazine in the Rat Brain and the First in vivo Spectrum of Fluphenazine in Human Brain, Biol. Psychiatry., 30, 656, 10.1016/0006-3223(91)90011-A Beckmann, 1990, Analysis of Glycogen Storage Disease by in vivo 13C NMR: Comparison of Normal Volunteers with a Patient, Magn. Reson. Med., 16, 150, 10.1002/mrm.1910160114 Berkowitz, 1991, Quantitative Determination of the Partial Oxygen Pressure in the Vitrectomized Rabbit Eye in vivo Using 19F NMR, Magn. Reson. Med., 21, 233, 10.1002/mrm.1910210208 Bloch, 1946, Nuclear Induction, Phys. Rev., 69, 127, 10.1103/PhysRev.69.127 Bottomley, 1989, Human in vivo NMR Spectroscopy in Diagnostic Medicine: Clinical Tool or Research Probe?, Radiology., 170, 1, 10.1148/radiology.170.1.2642336 Bottomley, 1992, Alzheimer Dementia: Quantification of Energy Metabolism and Mobile Phosphoesters with P-31 NMR Spectroscopy, Radiology., 183, 695, 10.1148/radiology.183.3.1584923 Boyer, 1989, An Overview of Fluoxetine, a New Serotonin-specific Antidepressant, Mt. Sinai J. Med., 56, 136 Branch, 1991, 19F NMR Imaging of Cerebral blood Flow, Magn. Reson. Med., 20, 151, 10.1002/mrm.1910200116 Brown, 1989, Ub cuci 31P NMR Profiles of Alzheimer's Disease and Multiple Subcortical Infarct Dementia, Neurology., 39, 1423, 10.1212/WNL.39.11.1423 Brown, 1993, Altered Brain Energy Metabolism in Demented Patients with Multiple Subcortical Ischemic Lesions, Working Hypotheses. Arch. Neurol., 50, 384, 10.1001/archneur.1993.00540040046012 Bruhn, 1993, Quantitative Proton MRS In Vivo Shows Cerebral Myo-Inositol and Cholines to be Unchanged in Manie-Depressive Patients Treated with Lithium, SMRM Book of Abstracts, 3, 1543 Brunetti, 1990, Cerebral Blood Flow in Experimental Ischemia Assessed by 19F Magnetic Resonance Spectroscopy in Cats, Stroke, 21, 1439, 10.1161/01.STR.21.10.1439 Buchsbaum, 1982, Cerebral Glucography with Positron Tomography. Use in Normal Subjects and in Patients with Schizophrenia, Arch. Gen. Psychiatry., 39, 251, 10.1001/archpsyc.1982.04290030001001 Caccia, 1990, Influence of Dose and Route of Administration on the Kinetics of Fluoxetine and its Metabolite Norfluoxetine in the Rat, Psychopharmacology., 100, 509, 10.1007/BF02244004 Cady, 1983, Noninvasive Investigation of Cerebral Metabolism in Newborn Infants by Phosphorus Nuclear Magnetic Resonance Spectroscopy, Lancet, 1, 1059, 10.1016/S0140-6736(83)91906-2 Calabrese, 1992, 31Phosphorus Magnetic Resonance Spectroscopy of the Temporal Lobes in Schizophrenia, Biol Psychiatry., 32, 26, 10.1016/0006-3223(92)90139-Q Chamuleau, 1991, What the Clinician Can Learn from MR Glutamine/Glutamate Assays, NMR Biomed., 4, 103, 10.1002/nbm.1940040213 Charles, 1992 Charles, 1993, Metabolic Brain Mapping in Alzheimer's Disease Using High Resolution Proton Spectroscopy, SMRM Book of Abstracts, 1, 228 Chen, 1992, An in vivo 19F NMR Study of Isoflurane Elimination as a Function of Age in Rat Brain, NMR Biomed., 5, 121, 10.1002/nbm.1940050304 Chong, 1993, Early Longitudinal Changes on Cerebral Proton Spectroscopy in HIV Infection with Clinical and MRI Correlation, SMRM Book of Abstracts, 1, 285 Christiansen, 1993, Reduced N-Acetyl Aspartate Content in Frontal Brain of Patients with Alzheimer's Disease, SMRM Book of Abstracts, 1, 226 Chu, 1992, Correlations Between Fluorine-19 Magnetic Resonance Chemical Shift and the Secondary and Tertiary Structure of 5-fluorouracil-substituted tRNA, J. Mol. Bio., 227, 1173, 10.1016/0022-2836(92)90529-S Connelly, 1993, The Contribution of 1H MRS to the Presurgical Assessment of Temporal Lobe Pathology in Patients with Intractable Epilepsy, SMRM book of Abstracts, 3, 1463 Constantinidis, 1991, In vivo 13C NMR Spectroscopy of Glucose Metabolism of RIF-1 Tumors, Magn. Reson. Med., 20, 17, 10.1002/mrm.1910200103 Cowley, 1990, The Diagnostic Utility of of Lactatc Sensitivity in Panic Disorder, Arch. Gen. Psychiatry., 47, 277, 10.1001/archpsyc.1990.01810150077012 Dager, 1992, Applications of Magnetic Resonance Spectroscopy to the Investigation of Neuropsychiatric Disorders, Neuropsychopharmacol., 6, 249 Dager, 1994, Preliminary Application of Magnetic Resonance Spectroscopy to Investigate Lactate-Induced Panic, Am. J. Psychiatry., 151, 57, 10.1176/ajp.151.1.57 Daly, 1989, Magnetic Resonance Spectroscopy of Tumors and Potential in vivo Clinical Applications: a Review, Cancer Res., 49, 770 Davidson, 1993, Magnetic Resonance Spectroscopy in Social Phobia: Preliminary Findings, J. Clin. Psychiatry., 54, 19 Detre, 1990, Measurement of Cerebral Blood Flow in Rat Brain by 19F-NMR Detection of Trifluoromethane Washout, Magn. Reson. Med., 16, 179 Devane, 1992, Pharmacokinetics of the Selective Serotonin Reuptake Inhibitors, J. Clin. Psychiatry., 13 Dubois, 1992, 19F-NMR Spin-spin Relaxation (T2) Method for Characterizing Volatile Anesthetic Binding to Proteins. Analysis of Isoflurane Binding to Serum Albumin, Biochem., 31, 7069, 10.1021/bi00146a007 Durst, 1990, Noninvasive in vivo Detection of a Fluorinated Neuroleptic in the Human Brain by 19F Nuclear Magnetic Resonance Spectroscopy, Psychiatry. Res.; Neuroimaging, 35, 107, 10.1016/0925-4927(90)90014-W l-Tahtawy, 1991, In vivo Measurements of Intratumoral Metabolism, Modulation, and Pharmacokinetics of 5-fluorouracil, using 19F Nuclear Magnetic Resonance Spectroscopy, Cancer Res., 51, 5806 Eleff, 1991, Sodium, ATP, and Intracellular pH Transients During Reversible Complete Ischemia of Dog Cerubrum, Stroke, 22, 233, 10.1161/01.STR.22.2.233 Eleff, 1993, Shift Reagent Enhanced Concurrent 23Na and 1H Magnetic Spectroscopic Studies of Transcellular Sodium Distribution in the Dog Brain in vivo, Magn. Res. Med., 30, 11, 10.1002/mrm.1910300104 Evenhuis, 1990, The Natural History of Dementia in Down's Syndrome, Arch. Neurol., 47, 263, 10.1001/archneur.1990.00530030029011 Everall, 1991, Neuronal Loss in the Frontal Cortex in HIV infection, Lancet, 337, 1119, 10.1016/0140-6736(91)92786-2 Felber, 1993, Localized Proton and Phosphorus Magnetic Resonance Spectroscopy Following Electroconvulsive Therapy, Biol. Psyichiatry., 33, 651, 10.1016/0006-3223(93)90106-N Fujimoto, 1992, Study of Chronic Schizophrenics Using 31P Magnetic Resonance Chemical Shift Imaging, Acta Psychiatr. Scand., 86, 455, 10.1111/j.1600-0447.1992.tb03297.x Fujimoto, 1993, Proton Spectroscopy Using MRS with 2T in Patinets with Epileptic Psychoses, SMRM book of Abstracts, 3, 1541 Gadian, 1993, 1H MRS and T2 Relaxometry of the Contralateral Temporal Lobe Following Epilepsy Surgery, SMRM book of Abstracts, 3, 1568 Gadian, 1993, Relationship of Cognitive Dysfunction to 1H MRS Assessment of Temporal Lobe Pathology, SMRM book of Abstracts, 1, 430 Glickson, 1989, Clinical NMR Spectroscopy of Tumors. Current Status and Future Directions, Invest. Radiol., 24, 1011, 10.1097/00004424-198912000-00020 Goodnick, 1991, Pharmacokinetics of Second Generation Antidepressants: Fluoxetine, Psychopharmacol. Bull., 27, 503 Guerquin-Kern, 1991, pH Dependence of 5-fluorouracil Uptake Observed by in vivo 31P and 19F Nuclear Magnetic Resonance Spectroscopy, Cancer Res., 51, 5770 Gunther, 1993, In vivo 19F Nuclear Magnetic Resonance of a Monofluorinated Neuroleptic in the Rat, NMR Biomed., 6, 27, 10.1002/nbm.1940060105 Gyulai, 1991, Measurement of Tissue Lithium Concentration by Lithium Magnetic Resonance Spectroscopy in Patients with Bipolar Disorder, Biol. Psychiatry., 29, 1161, 10.1016/0006-3223(91)90324-F Harada, 1991, In-vivo 19F-MRS study of 5-fluorouracil (5-FU) on Metabolism on Tumors, Gan To Kagaku Ryoho., 18, 75 Harada, 1992, In vivo 19F MRSpectoscopic Study of Metabolism of 5-fluorotryptophan in Rat Liver, Acta Radiol., 33, 258, 10.1177/028418519203300313 Hees, 1993, Assessment of Changes in Murine Tumor Oxygenation in Response to Nicotinamide using 19F NMR Relaxometry of a Perfluocarbon Emulsion, Magn. Reson. Med., 29, 716 Hida, 1992, In Vivo 1H and 31P NMR Spectroscopy of the Developing Rat Brain, Magn. Reson. Med., 23, 31, 10.1002/mrm.1910230105 Hope, 1991, Magnetic Resonance Spectroscopy, Clin. Perinatol., 18, 535, 10.1016/S0095-5108(18)30511-6 Ide, 1993, 1H-CSI Study of the Alzheimer Disease, SMRM Book of Abstracts, 1, 231 Itoh, 1993, Evaluation of Neuronal Changes in Brain with Alzheimer's Disease using Localized Proton MR Spectroscopy, SMRM Book of Abstracts, 1, 229 Jackson, 1993, Single Volume Proton MR Spectroscopy in Patients with Intractable Temporal Lobe Epilepsy: A Multicenter Pilot Study, SMRM book of Abstracts, 3, 1567 Jarvik, 1993, Proton MR Spectroscopy of HIV-infected Patients: Characterization of Abnormalities with Imaging and Clinical Correlation, Radiology., 186, 739, 10.1148/radiology.186.3.8430182 Jungling, 1993, Localized 1H-spectroscopy in the Hippocampus of Normals and Patients with Alzheimer's Disease, SMRM Book of Abstracts, 3, 1555 Jynge, 1990, In vivo Tissue Pharmacokinetics by Fluorine Magnetic Resonance Spectroscopy: a Study of Liver and Muscle Disposition of Fleroxacin in Humans. Clinical Pharmacology and Therapeutics, Magn. Reson. Spectroscopy, 48, 481 Karson, 1992, Fluoxetine and Trifluoperazine in Human Brain: A 19F-Nuclear Magnetic Resonance Spectroscopy Study., Psychiatry. Res., 45, 95, 10.1016/0925-4927(92)90003-M Karson, 1993, Human Brain Fluoxetine Concentrations, J. Neuropsychiatry Clin Neurosci., 5, 322, 10.1176/jnp.5.3.322 Kato, 1992, Brain Lithium Concentration by 7Li- and 1H-Magnetic Resonance Spectroscopy in Bipolar Disorder, Psychiatry Res., 45, 53, 10.1016/0925-4927(92)90013-T Kato, 1992, Brain Phosphorus Metabolism in Depressive Disorders Detected by Phosphorus-31 Magnetic Resonance Spectroscopy, J. Affect. Disord., 26, 223, 10.1016/0165-0327(92)90099-R Kato, 1993, Alterations in Brain Phosphorus Metabolism in Bipolar Disorder Detected by in vivo 31P and 7Li Magnetic Resonance Spectroscopy, J. Affect. Disord., 27, 53, 10.1016/0165-0327(93)90097-4 Kauppinen, 1993, Applications of Magnetic Resonance Spectroscopy and Diffusion-weighted Imaging to the Study of Brain Biochemistry and Pathology, TINS, 16, 88 Keshavan, 1991, Magnetic Resonance Spectroscopy in Psychiatry: Potential, Pitfalls, and Promise, Am. J. Psychiatry., 148, 976 Kesslak, 1993, Single Volume Proton Spectroscopy in Alzheimer's Disease Patients: A Multicenter Pilot Study, SMRM Book of Abstracts, 1, 227 Kim, 1990, Quantification of Regional Blood Flow by Monitoring of Exogenous Tracer via Nuclear Magnetic Resonance Spectroscopy, Magn. Reson. Med., 14, 266, 10.1002/mrm.1910140212 Klunk, 1992, NAA and Other Amino Acid Metabolites in Alzheimer's Disease Brain: a Preliminary Proton Nuclear Magnetic Resonance Study, Neurology., 42, 1578, 10.1212/WNL.42.8.1578 Knuttel, I991, Motion-insensitive Volume-selective Pulse Sequences for Direct and Proton-detected 13C Spectroscopy: Detection of Glycogen in the Human Liver in vivo, Magn. Reson. Med., 17, 470, 10.1002/mrm.1910170218 Kohler, 1993, PROBE/SV Signa Applications Guide, GE Medical Systems, Vol. 5, 1 Komoroski, 1990, In vivo NMR Spectroscopy of Lithium-7 in Humans, Magn. Reson. Med., 15, 347, 10.1002/mrm.1910150302 Komoroski, 1991, Detection of Psychoactive Drugs in vivo in Humans Using 19F NMR Spectroscopy, Biol. Psychiatry., 29, 711, 10.1016/0006-3223(91)90146-D Komoroski, 1994, In Vivo 19F Spin Relaxation and Localized Spectroscopy of Fluoxetine in Human Brain, Magn. Reson. Med., 31, 204, 10.1002/mrm.1910310214 Kushnir, 1993, Relaxation Times and Concentrations of 7Li in the Brain of Patients Receiving Lithium Therapy, NMR Biomed., 6, 39, 10.1002/nbm.1940060107 Kwee, 1991, 31P and 3-flouro-3deoxy-D-glucose 19F in vivo NMR Spectroscopy of Aged Rat Brain, NMR Biomed., 4, 38, 10.1002/nbm.1940040107 Lai, 1989, A Prospective Study of Alzheimer's Disease in Down's Syndrome, Arch. Neurol., 46, 849, 10.1001/archneur.1989.00520440031017 Laubenberger, 1992, Proton Spectroscopy of the Brain in HIV-Infected Patients, Radiology., 300 Lauterbur, 1973, Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance, Nature, 242, 190, 10.1038/242190a0 Lee, 1992, Percutaneous Absorption of Flurbiprofen in the Hairless Rat Measured in vivo Using 19F Magnetic Resonance Spectroscopy, J. Invest. Dermatol., 99, 431, 10.1111/1523-1747.ep12616137 Lenkinski, 1993, Proton MRS Studies of HIV Seropositive Asymptomatic Patients, SMRM Book of Abstracts, 1, 284 Litt, 1991, In vivo 19F Nuclear Magnetic Resonance Brain Studies of Halothane, Isoflurane, and Desflurane. Rapid Elimination and no Abundant Saturable Binding, Ann NY Acad. Sci., 625, 707, 10.1111/j.1749-6632.1991.tb33904.x Lock, 1990, Psychiatry and the New Magnetic Resonance Era, Br. J. Psychiatry., 157, 38, 10.1192/S0007125000291848 Malet-Martino, 1990, Fluorine-19 Nuclear Magnetic Resonance Spectroscopy: A Privileged Tool for the Study of the Metabolism and Pharmacokinetics of Fluoropyrimidines, Bull. Cancer., 77, 1233 Mason, 1992, A Noninvasive Assessment of Myocardail Oxygen Tension: 19F NMR Spectroscopy of Sequestered Perfluorocarbon Emulsion, Magn. Reson. Med., 27, 310, 10.1002/mrm.1910270210 Maxwell, 1991, 19F Nuclear Magnetic Resonance Imaging of Drug Distribution in vivo: the Disposition of an Antifolate Anticancer Drug in Mice, Magn. Reson. Med., 17, 189, 10.1002/mrm.1910170122 Mcneill, 1991, Uptake of Fluorine in Cortical and Trabecular Bone, J. Bone Miner. Res., 6, 859, 10.1002/jbmr.5650060811 Meeh, 1992, Quanitification of the Accumulation and Degradation of Beta-very-low-density Lipoproteins in vivo Using a 19F-containing Residualizing Label and NMR Spectroscopy, Biochem.J., 286, 785, 10.1042/bj2860785 Menon, 1990, Proton MR Spectroscopy and Imaging of the Brain in AIDS: Evidence of Neuronal Loss in Regions that Appear Normal with Imaging, J. Comput. Assist. Tomogr., 14, 882, 10.1097/00004728-199011000-00003 Menon, 1992, Proton MR Spectroscopy of the Brain in AIDS Dementia Complex, J. Comput. Assist. Tomogr., 16, 538, 10.1097/00004728-199207000-00007 Miatto, 1986, In Vitro 31-P NMR Spectroscopy Detects Altered Phospholipid Metabolism in Alzheimer's Disease, Can. J. Neurol. Sci., 13, 535, 10.1017/S0317167100037276 Miller, 1993, Alzheimer Disease: Depiction of Increased Cerebral Myo-inositol with Proton MR Spectroscopy, Radiology., 187, 433, 10.1148/radiology.187.2.8475286 Minshew, 1993, A Preliminary 31P MRS Study of Autism: Evidence for Undersynthesis and Increased Degradation of Brain Membranes, Biol. Psychiatry., 33, 762, 10.1016/0006-3223(93)90017-8 Mishima, 1991, In vivo F-19 Chemical Shift Imaging with FTPA and Antibody-coupled FMIQ, J. Magn. Reson. Imaging., 1, 705, 10.1002/jmri.1880010616 Moats, 1993, In vivo Quantitative 1H Difference Spectroscopy in Patients with Probable Alzheimer Disease, SMRM Book of Abstracts, 1, 230 Moon, 1973, Determination of Intracellular pH by 31-P Magnetic Resonance, J. Biol. Chem., 248, 7276, 10.1016/S0021-9258(19)43389-9 Murata, 1993, In Vivo Proton Magnetic Resonance Spectroscopy Study on Premature Aging in Adult Down's Syndrome, Biol. Psychiatry., 34, 290, 10.1016/0006-3223(93)90086-S Murphy, 1993, An in vivo Study of Phosphorus and Glucose Metabolism in Alzheimer's Disease Using Magnetic Resonance Spectroscopy and PET, Arch. Gen. Psychiatry., 50, 341, 10.1001/archpsyc.1993.01820170019003 Murphy-Boesch, 1993, Proton-decoupled 31P Chemical Shift Imaging of the Human Brain in Normal Volunteers, NMR Biomed., 6, 173, 10.1002/nbm.1940060302 Nakada, 1989, One Dimensional Chemical Shift Imaging of Fluorinated Neuroleptics in Rat Brain in vivo by 19F NMR Rotating Frame Zeugmatography, Magn. Reson. Imaging., 7, 543, 10.1016/0730-725X(89)90408-6 Naser-Hijazi, 1991, Locoregional Administration of 5-fluoro-2′-deoxyuridine (FdUrd) in Novikoff Hepatoma in the Rat: Effects of Dose and Infusion Time on Tumor Growth and on FdUrd Metabolite Levels in Tumor Tissue as Determined by 19F NMR Spectroscopy, J. Cancer Res. and Clin. Onc., 117, 295, 10.1007/BF01630711 Neil, 1991, The Validation of Freely Diffusible Tracer Methods with NMR Detection for Measurement of Blood Flow, Magn. Reson. Med., 19, 299, 10.1002/mrm.1910190218 Noguchi, 1989, Application of 31-P-Magnetic Resonance Imaging to Senile Dementia of Alzheimer Type, SMRM Book of Abstracts, 2, 669 O'Callaghan, 1991, Initial Investigation of the Left Temporoparietal Region in Schizophrenia by 31-P Magnetic Resonance Spectroscopy, Biol. Psychiatry., 29, 1149, 10.1016/0006-3223(91)90256-L Paley, 1993, Short Echo Time Spectroscopy in AIDS, SMRM Book of Abstracts, 3, 1561 Pary, 1989, Fluoxetine: Prescribing Guidelines for the Newest Antidepressant, South. Med. J., 82, 1005, 10.1097/00007611-198908000-00019 Petroff, 1992, Cerebral Lactate Turnover after Electoshock: In vivo Measurements by 1H13C Magnetic Resonance Spectroscopy, J. Cereb. Blood Flow Metab., 12, 1022, 10.1038/jcbfm.1992.139 Petroff, 1993, The Effect of Vigabatrin on GABA, Glutamate, and Glutamine Levels in Human Brain Measured in vivo with 1H NMR Spectroscopy, SMRM Book of Abstracts, 1, 434 Pettegrew, 1991, Alterations in Brain High-energy and Membrane Phospholipid Metabolism in First-episode, Drug Naive Schizophrenics, Arch. Gen. Psychiatry., 48, 563, 10.1001/archpsyc.1991.01810300075011 Pettegrew, 1988, Correlation of 31-P Magnetic Resonance Spectroscopy and Morphological Findings in Alzheimer's Disease, Arch. Neurol., 45, 1093, 10.1001/archneur.1988.00520340047010 Port, 1991, Kinetic Modeling of in vivo-Nuclear Magnetic Resonance Spectroscopy Data: 5-fluorouracil in Liver and Liver Tumors, Clin. Pharm. Ther., 49, 497, 10.1038/clpt.1991.60 Pouremad, 1991, Cerebral Metabolism of Fluorodeoxyglucose Measured with 19F NMR Spectroscopy, NMR Biomed., 4, 161, 10.1002/nbm.1940040402 Preece, 1992, 19F NMR Studies of Enflurane Elimination and Metabolism, NMR Biomed., 5, 101, 10.1002/nbm.1940050209 Purcell, 1946, Resonance Absorption by Nuclear Magnetic Movements in a Solid, Phys. Rev., 69, 37, 10.1103/PhysRev.69.37 Ramaprasad, 1992, In vivo 7Li NMR Imaging and Localized Spectroscopy of the Rat Brain, Mag. Res. Med., 25, 308, 10.1002/mrm.1910250209 Renshaw, 1992, Accumulation of Fluoxetine and Norfluoxetine in Human Brain During Therapeutic Administration, Am. J. Psychiatry., 149, 1592, 10.1176/ajp.149.11.1592 Renshaw, 1993, Parietal Lobe Proton MRS in Patients with Alzheimer's Disease, SMRM Book of Abstracts, 1, 232 Renshaw, 1993, Proton MRS Studies of the Basal Ganglia in Major Depression: Side and Treatment Effects, SMRM Book of Abstracts, 1, 433 Rothman, 1993, Localized 1H NMR Measurements of Gammaaminobutyric Acid in Human Brain in vivo, 90, 5662 Rotrosen, 1987, Phospholipid and Prostaglandin Hypotheses of Schizophrenia Schanne, 1989, Lead Increases Free Ca2+ Concentration in Cultured Osteoblastic Bone Cells: Simultaneous Detection of Intracellular Free Pb2+ by 19F NMR, 86, 5133 Schanne, 1990, Effect of Lead on Parathyroid Hormon-induced Responses in Rat Osteoblastic Osteosarcoma Cells Using 19F-NMR, Biochim. Biophys. Acta., 1054, 250, 10.1016/0167-4889(90)90249-D Selinsky, 1991, 19F Nuclear Magnetic Resonance Analysis of Trifluoroethanol Metabolites in the Urine of the Sprague-Dawley Rat, Biochem. Pharmacol., 42, 2229, 10.1016/0006-2952(91)90360-H Semmler, 1990, Real-time Follow-up of 5-Fluorouracil Metabolism in the Liver of Tumor Patients by Means of F-19 MR Spectroscopy, Radiology., 174, 141, 10.1148/radiology.174.1.2104675 Seto, 1992, The Solubility of Volatile Anaesthetics in Water at 25.0 Degrees C Using 19F NMR Spectroscopy, J. Pharm. Biomed. Anal., 10, 1, 10.1016/0731-7085(92)80003-6 Shaw, 1988, The Fundamental Principles of Nuclear Magnetic Resonance, 1 Shinohara, 1991, Evaluation of Energy Metabolism in Brain using Epimerization of 2-deoxy-2-fluoro-D-glucose by 19F NMR: the Effet of Anesthesia, Magn. Reson. Med., 21, 191, 10.1002/mrm.1910210204 Shulman, 1993, Nuclear Magnetic Resonance Imaging and Spectroscopy of Human Brain Function, 90, 3127 Sijens, 1991, Multinuclear MR Investigation of the Metabolic Response of the Murine RIF-1 Tumor to 5-fluorouracil Chemotherapy, Magn. Reson. Med., 19, 373, 10.1002/mrm.1910190228 Smith, 1993, 31P Magnetic-Resonance Spectroscopy in Alzheimer's Disease and Pick's Disease, Neurobiol. Aging., 14, 85, 10.1016/0197-4580(93)90026-8 Stanley, 1991, Membrane Phospholipid Metabolism Abnormalities in the Left Prefrontal Cortex in Drug-Naive and Chronic Schizophrenics via 31-P NMR Spectroscopy, SMRM Book of Abstracts, 3, 1062 Stoll, 1992, The Human Brain Resonance of Choline-Containing Compounds is Similar in Patients Receiving Lithium Treatment and Controls: An In Vivo Proton Magnetic Resonance Spectroscopy Study, Biol. Psychiatry., 32, 944, 10.1016/0006-3223(92)90184-2 Stokes, 1993, Fluoxetine: A Five Year Review, Clin. Ther., 15, 216 Thomas, 1992, Use of Fluorine-19 NMR Spectroscopy and Hydralazine for Measuring Dynamic Changes in Blood Perfusion Volume in Tumors in Mice, J. Natl. Cancer Inst., 84, 174, 10.1093/jnci/84.3.174 Urenjak, 1993, Proton Nuclear Magnetic Resonance Spectroscopy Unambiguously Identifies Different Neural Cell Types, J. Neuroscience., 13, 981, 10.1523/JNEUROSCI.13-03-00981.1993 Van Der Knaap, 1990, Age-dependent Changes in Localized Proton and Phosphorus MR Spectroscopy of the Brain, Radiology., 176, 509, 10.1148/radiology.176.2.2164237 Van Zijl, 1990, Measurement of Cerebral Blood Flow by Volume-Selective 19F NMR Spectroscopy, Magn. Reson. Med., 16, 489, 10.1002/mrm.1910160316 Van Zijl, 1993, Proton Spectroscopy and Spectroscopic Imaging of the Brain, SMRM Book of Abstracts, 1, 367 Vion-Dury, 1993, Localized Brain Proton MRS in Neurologic Complications of AIDS: Value for Diagnosis and Prognosis, SMRM Book of Abstracts, 3, 1563 Wade, 1990, 19F and 1H Magnetic Resonance Strategies for Metabolic Studies on Fluorinated Xenobiotics: Application to Flurbiprofen, J. Pharm. Biomed. Anal., 8, 401, 10.1016/0731-7085(90)80067-Y Weiner, 1988, Progress in Clinical Radiology: The promise of Magnetic Resonance Spectrocopy for Medical Diagnosis, Invest. Radiol., 23, 253, 10.1097/00004424-198804000-00003 Williamson, 1991, Localized Phosphorus 31 Magnetic Resonance Spectroscopy in Chronic Schizophrenic Patients and Normal Controls, Arch. Gen. Psychiatry., 48, 528 Wilson, 1992, Measurements of Preretinal Oxygen Tension in the Vitrectomized Human Eye Using 19F NMR, Arch. Opthalmol., 110, 1098, 10.1001/archopht.1992.01080200078028 Wyrwicz, 1989, Determination of Halothane Distribution in the Rat Head Using 19F NMR Technique, Magn. Reson. Med., 9, 219, 10.1002/mrm.1910090207 Wyrwicz, 1991, 19F in vivo NMR Spectroscopy: A New Technique to Probe Fluorinated Anesthetic-tissue Interactions, Ann NY Acad. Sci., 625, 733, 10.1111/j.1749-6632.1991.tb33906.x Yurgelun-Todd, 1993, 1H Spectroscopy of the Temporal Lobes in Schizophrenia and Bipolar Patients, SMRM Book of Abstracts, 3, 1539